Pharmaceutical NanotechnologyMixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin
Introduction
Currently, polymeric micelles are popular pharmaceutical nanocarriers for the delivery of poorly water-soluble drugs, which can be solubilized within the hydrophobic inner core of a micelle (Bader et al., 1984, Jones and Leroux, 1999). As a result, micelles can substantially improve solubility and bioavailability of various hydrophobic drugs (Lukyanov and Torchilin, 2004). The small size (10–100 nm) of micelles allows for the micelle efficient accumulation in pathological tissues with the permeabilized (“leaky”) vasculature, such as tumors and infarcts, via the enhanced permeability and retention (EPR) effect (Wu et al., 1993, Maeda et al., 2000, Torchilin, 2001); in addition, this small size offers the advantage of simple sterilization of micelles by filtration through polycarbonate membranes with the cut off size of 0.2 μm.
Among other polymeric micelles, micelles prepared from conjugates of polyethylene glycol (PEG) and diacyllipids, such as phosphatidylethanolamine (PE)—PEG–PE conjugates—have demonstrated high stability and low toxicity (Torchilin, 2002, Lukyanov et al., 2002). The very low CMC value of PEG–PE compounds (in a 10−5 M range) indicates that PEG–PE micelles can preserve their integrity even upon the dilution in the blood pool during the supposed therapeutic application (Lukyanov and Torchilin, 2004). In our previous studies, we have successfully encapsulated a number of poorly soluble anticancer drugs into PEG–PE micelles with high efficiency and stability (Gao et al., 2002, Mu et al., 2005).
Camptothecin (CPT), a plant alkaloid from Camptotheca acuminate (Wall et al., 1966) demonstrated strong antitumor activity against lung, ovarian, breast, pancreas, and stomach cancers (Giovanella and Cheng, 1991, Wall and Wani, 1995) by targeting intracellular topoisomerase I, a nuclear enzyme that reduces the torsional stress of supercoiled DNA (Hsiang and Liu, 1988, Garcia-Carbonero and Supko, 2002). However, CPT is insoluble in water (Hatefi1 and Amsden, 2002) and exists in two forms depending on the pH value: the active lactone forms at pH below 5 and the inactive open ring-carboxylated CPT-Na+ form, which present at neutral pH values (Wall, 1969, Fassberg and Stella, 1992). Although the lactone form of CPT is crucial for its anticancer activity, at physiological pH values most CPT molecules exist in the inactive carboxylate form. Thus, sparing solubility and labile lactone ring hinder the clinical application of CPT.
Various formulation strategies have been designed to increase the solubility of CPT, stabilize the lactone ring, and reduce the systemic toxicity of this drug, which involve solid lipid nanoparticles (Yang et al., 1999), microparticles (Shenderova et al., 1997), and liposomes (Tardi et al., 2000). Polymeric micelles also can effectively solubilize and stabilize CPT (Cortesi et al., 1997, Barreiro-Iglesiasa et al., 2004, Opanasopit et al., 2004), and enhance the antitumor efficiency of the encapsulated CPT due to the spontaneous accumulation in tumor tissues via the EPR effect (Maeda et al., 2000, Jain, 1997). CPT incorporation into PEG–PE micelles recently described by us (Mu et al., 2005), allowed for the preparations with significantly higher CPT concentrations than described earlier (Cortesi et al., 1997, Barreiro-Iglesiasa et al., 2004, Opanasopit et al., 2004).
One may expect that further increase in the efficiency of micellar solubilization of CPT might be achieved by using mixed micelles as shown for some other poorly soluble drugs (Krishnadas et al., 2003). Interestingly, d-α-tocopheryl polyetheyene glycol 1000 succinate (TPGS), a derivative of the natural Vitamin E (α-tocopherol) and polyetheyene glycol 1000 is used as solubilizer, absorption enhancer and a vehicle for lipid-based drug delivery formulations (Eastman, 1998, Mu and Feng, 2003). It was also reported that succinate esters of Vitamin E, such as RRR-α-tocopheryl succinate, behave as potent, pro-apoptotic agent selective for cancer cells (Yu et al., 2001, Neuzil et al., 2001). TPGS itself can hardly be used as micelle-forming material to carry CPT because of the relatively low CMC value (approximately 1.3 × 10−4 M for industrial grade TPGS (Eastman, 1998), which may result in micelle dissociation in the blood, however its lipophilic portion is relatively bulky, which might allow for better drug solubilization if TPGS is used as a component of the mixed micellar drug delivery system. One can hypothesize that mixed micelles made of TPGS and PEG–PE if used as CPT carriers may allow for the better drug encapsulation and high anticancer efficiency.
Here, we describe the preparation of CPT-loaded mixed PEG–PE/TPGS micelles, some of their properties and increased in vitro cytotoxicity against several tumor cell lines.
Section snippets
Materials
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PEG–PE) was purchased from Avanti Polar Lipids, Inc. (Alabaster, AL) and used without further purification. Camptothecin (CPT) was purchased from Sigma–Aldrich (St. Louis, MO, USA). d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) was received as a gift from Eastman Co. (USA). All other reagents and components of buffer solutions were analytical grade preparations. Distilled and deionized water was
Micelle size, stability and CPT incorporation
All prepared micelles, with or without CPT load, had the mean diameter of approximately 12 nm and size distribution from 6 to 20 nm. The single peak on HPLC profile (Fig. 1) confirmed the formation of CPT-loaded PEG–PE/TPGS mixed micelles (certain asymmetry of the baseline around the peak may be explained by too high micelle concentration used since it diminished with the dilution). The dilution of the micelle sample influenced only the amplitude of the HPLC peak, without affecting its position
Conclusion
Micelles from mixture of TPGS and PEG–PE conjugates (2:1 molar ratio) provide a more efficient solubilization of the poorly soluble anticancer drug, camptothecin (CPT), than the micelles made of PEG–PE alone. PEG–PE/TPGS mixed micelles firmly retain the incorporated CPT and demonstrate dramatically enhanced cytotoxicity against several tested murine and human cancer cell lines compared to the free drug. The enhanced cytotoxicity of CPT-loaded mixed micelles can be attributed to several factors:
Acknowledgement
This work was supported by NIH Grant R01 EB001961 to Vladimir P. Torchilin.
References (31)
- et al.
Water soluble polymers in medicine
Angew. Makromol. Chem.
(1984) - et al.
Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers
J. Controlled Release
(2004) - et al.
Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles
J. Controlled Release
(2004) - et al.
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion
Int. J. Pharm.
(1997) - Eastman Chemical Company, USA, October 1998. Publication...
- et al.
A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues
J. Pharm. Sci.
(1992) - et al.
Diacyl–polymer micelles as nanocarriers for poorly soluble anticancer drugs
Nano Lett.
(2002) - et al.
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins
Clin. Cancer Res.
(2002) - et al.
Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-Scamptothecin
Cancer Res.
(1991) - et al.
Camptothecin delivery methods
Pharm. Res.
(2002)
Identification of mammalian topoisomerate I as an intracellular target of the anticancer drug camptothecin
Cancer Res.
Delivery of molecular and cellular medicine to solid tumors
Adv. Drug Deliv. Rev.
Polymeric micelles—a new generation of colloidal drug carriers
Eur. J. Pharm. Biopharm.
Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs
Pharm. Res.
Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice
Pharm. Res.
Cited by (167)
Development and characterization of self-assembling sirolimus-loaded micelles as a sublingual delivery system
2022, Journal of Drug Delivery Science and TechnologyCitation Excerpt :Therefore, the amount of SRL was reduced to 22.5 mg (SRL/amphiphile ratio = 22.5/100, w/w), to attain an hydrodynamic diameter, PDI, and zeta potential similar to those of SM9, SM10 and SM11 (Table 2). These results are consistent with a previous research which suggested that the hydrophobic drugs dissolved in the hydrophobic core region of TPGS micelles have essentially no impact on the size of micelles [57]. Loading the blank TPGS micelles with 20 mg of SRL (SRL/amphiphile ratio = 20/100, w/w) resulted in DL and EE values of 16.65 ± 0,134% and 99.91 ± 0.963%, respectively.
One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates
2022, Bioconjugate ChemistryA modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment
2021, Journal of Controlled ReleaseMultifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer
2021, Materials Science and Engineering C